-
1
-
-
33750809498
-
Treatment of intractable hiccups with olanzapine following recent severe traumatic brain injury
-
Alderfer B.S., and Arciniegas D.B. Treatment of intractable hiccups with olanzapine following recent severe traumatic brain injury. J Neuropsychiatry Clin Neurosci 18 4 (2006) 551-552
-
(2006)
J Neuropsychiatry Clin Neurosci
, vol.18
, Issue.4
, pp. 551-552
-
-
Alderfer, B.S.1
Arciniegas, D.B.2
-
2
-
-
0032963483
-
Persistent hiccups induced by dexamethasone
-
Ross J., Eledrisi M., and Casner P. Persistent hiccups induced by dexamethasone. West J Med 170 (1999) 51-52
-
(1999)
West J Med
, vol.170
, pp. 51-52
-
-
Ross, J.1
Eledrisi, M.2
Casner, P.3
-
4
-
-
0033048256
-
Drug-induced hiccup: a review of the France pharmacologic vigilance database
-
Bagheri H., Cismondo S., and Montastruc J.L. Drug-induced hiccup: a review of the France pharmacologic vigilance database. Therapie 54 1 (1999) 35-39
-
(1999)
Therapie
, vol.54
, Issue.1
, pp. 35-39
-
-
Bagheri, H.1
Cismondo, S.2
Montastruc, J.L.3
-
7
-
-
0033922193
-
Sertraline in the treatment of hiccups
-
Vaidya V. Sertraline in the treatment of hiccups. Psychosomatics 41 (2000) 4
-
(2000)
Psychosomatics
, vol.41
, pp. 4
-
-
Vaidya, V.1
-
8
-
-
33746915181
-
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease
-
Solla P., Congia S., and Secchi L. Clozapine-induced persistent hiccup in a patient with Alzheimer's disease. Clin Neurol Neurosurg 108 (2006) 614-618
-
(2006)
Clin Neurol Neurosurg
, vol.108
, pp. 614-618
-
-
Solla, P.1
Congia, S.2
Secchi, L.3
-
9
-
-
0025325124
-
Serotonergic control of phrenic motoneuronal activity at the level of the spinal cord of the rabbit
-
Schmid K., Bohmer G., and Merkelbach S. Serotonergic control of phrenic motoneuronal activity at the level of the spinal cord of the rabbit. Neurosci Lett 116 (1990) 204-209
-
(1990)
Neurosci Lett
, vol.116
, pp. 204-209
-
-
Schmid, K.1
Bohmer, G.2
Merkelbach, S.3
-
10
-
-
33749237842
-
Spinal activation of serotonin 1A receptors enhances latent respiratory activity after spinal cord injury
-
Zimmer M.B., and Goshgarian H.G. Spinal activation of serotonin 1A receptors enhances latent respiratory activity after spinal cord injury. J Spinal Cord Med. 29 2 (2006) 147-155
-
(2006)
J Spinal Cord Med.
, vol.29
, Issue.2
, pp. 147-155
-
-
Zimmer, M.B.1
Goshgarian, H.G.2
-
11
-
-
34249006023
-
Alpha-2-delta ligands for singultus (hiccup) treatment: three case reports
-
Jatzko A., Stegmeier-Petroianu A., and Petroianu G.A. Alpha-2-delta ligands for singultus (hiccup) treatment: three case reports. J Pain Symptom Manage 33 6 (2007) 756-760
-
(2007)
J Pain Symptom Manage
, vol.33
, Issue.6
, pp. 756-760
-
-
Jatzko, A.1
Stegmeier-Petroianu, A.2
Petroianu, G.A.3
-
12
-
-
34250880363
-
Aripiprazole-induced hyponatremia
-
Ginsberg D.L. Aripiprazole-induced hyponatremia. Prim Psychiatry 14 6 (2007) 19-22
-
(2007)
Prim Psychiatry
, vol.14
, Issue.6
, pp. 19-22
-
-
Ginsberg, D.L.1
-
13
-
-
0042887023
-
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
-
Shapiro D.A., Renock S., Arrington E., et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28 (2003) 1400-1411
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 1400-1411
-
-
Shapiro, D.A.1
Renock, S.2
Arrington, E.3
-
14
-
-
0037177358
-
The antipsychotic aripiprazole is a potent, partial agonist at the 5-HT1A receptor
-
Jordan S., Koprivica V., Chen R., et al. The antipsychotic aripiprazole is a potent, partial agonist at the 5-HT1A receptor. Eur J Pharmacol 441 (2002) 137-140
-
(2002)
Eur J Pharmacol
, vol.441
, pp. 137-140
-
-
Jordan, S.1
Koprivica, V.2
Chen, R.3
-
15
-
-
6044224986
-
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side effect profile
-
Hirose T., Uwahodo Y., Yamada S., et al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side effect profile. J Psychopharmacol 18 (2004) 375-383
-
(2004)
J Psychopharmacol
, vol.18
, pp. 375-383
-
-
Hirose, T.1
Uwahodo, Y.2
Yamada, S.3
-
16
-
-
9944225707
-
Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism
-
Naber D., and Lambert M. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 1213-1219
-
(2004)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.28
, pp. 1213-1219
-
-
Naber, D.1
Lambert, M.2
-
17
-
-
30144434333
-
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist
-
Hirose T., and Kikucchi T. Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist. J Med Invest 52S (2005) 1284-1290
-
(2005)
J Med Invest
, vol.52 S
, pp. 1284-1290
-
-
Hirose, T.1
Kikucchi, T.2
-
18
-
-
34248545611
-
Pharmacokinetics of aripiprazole and concomitant carbamazepine
-
Citrome L., Macher J.P., Salazar D.E., et al. Pharmacokinetics of aripiprazole and concomitant carbamazepine. J Clin Psychopharmacol 27 3 (2007) 279-283
-
(2007)
J Clin Psychopharmacol
, vol.27
, Issue.3
, pp. 279-283
-
-
Citrome, L.1
Macher, J.P.2
Salazar, D.E.3
-
19
-
-
1542754971
-
Aripiprazole
-
Winans E. Aripiprazole. Am J Health-Syst Pharm 60 23 (2003) 2437-2445
-
(2003)
Am J Health-Syst Pharm
, vol.60
, Issue.23
, pp. 2437-2445
-
-
Winans, E.1
-
20
-
-
0022605470
-
Therapy-resistant singultus and reflux esophagitis
-
Guyot J. Therapy-resistant singultus and reflux esophagitis. Dtsch Med Wochenschr 111 (1986) 314-315
-
(1986)
Dtsch Med Wochenschr
, vol.111
, pp. 314-315
-
-
Guyot, J.1
|